Agilent Technologies Inc. (Santa Clara, California) has agreed to purchase Varian, Inc. (Palo Alto, California) for $1.5 billion or $52 per share.
Agilent Technologies Inc. (Santa Clara, California) has agreed to purchase Varian, Inc. (Palo Alto, California) for $1.5 billion or $52 per share. According to Agilent, the acquisition broadens its' applications and solutions offerings in life sciences, environmental, and energy and materials. It also expands the company’s product portfolio into atomic and molecular spectroscopy; establishes a leading position in NMR, imaging, and vacuum technologies; and strengthens its consumables portfolio.
“This acquisition is a major step in Agilent’s transformation into a leading bio-analytical measurement company,” said Bill Sullivan, Agilent’s president and chief executive officer.
The transaction is expected to generate $75 million in annual cost synergies and achieve Agilent’s 20% return on invested capital (ROIC) target within four to five years. The transaction is subject to approval by the shareholders of Varian and will be completed after achieving customary closing conditions and regulatory approvals, which Agilent expects before calendar year-end.
LC–MS/MS-Based System Used to Profile Ceramide Reactions to Diseases
April 26th 2024Scientists from the University of Córdoba in Córdoba, Spain recently used liquid chromatography–tandem mass spectrometry (LC–MS/MS) to comprehensively profile human ceramides to determine their reactions to diseases.
High-Throughput 4D TIMS Method Accelerates Lipidomics Analysis
April 25th 2024Ultrahigh-pressure liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) had been previously proposed for untargeted lipidomics analysis, but this updated approach was reported by the authors to reduce run time to 4 min.